| Dr Garland R Tschudin, MD | |
|
12348 Old Tesson Rd Ste 160, Saint Louis, MO 63128 | |
| (314) 467-3800 | |
| Not Available |
| Full Name | Dr Garland R Tschudin |
|---|---|
| Gender | Male |
| Speciality | General Practice |
| Location | 12348 Old Tesson Rd Ste 160, Saint Louis, Missouri |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013978394 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208D00000X | General Practice | R7077 (Missouri) | Primary |
| Entity Name | Mercy Clinic East Communities |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1851335228 PECOS PAC ID: 7214827922 Enrollment ID: O20070521000006 |
News Archive
Mesenchymal stem cells (MSCs) have been transplanted to successfully treat a variety of diseases and conditions. The benefit of using MSCs is their ability to self-renew and differentiate into a variety of specialized cell types, such as osteoblasts (cells contributing to bone formation), chondrocytes (cartilage cells), adipocytes (fat cells), myocardiocytes (the muscle cells that make up the cardiac muscle), and neurons (nervous system cells).
Ligand Pharmaceuticals Incorporated today announced that its licensee, Onyx Pharmaceuticals, received accelerated approval from the U.S. Food and Drug Administration (FDA) for Kyprolis (carfilzomib) for Injection, a proteasome inhibitor indicated for the treatment of patients with multiple myeloma who have received at least two prior therapies, including bortezomib and an immunomodulatory agent, and have demonstrated disease progression on or within 60 days of completion of the last therapy.
Biodel Inc. announced today that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) requesting additional information regarding the company's new drug application (NDA) for Linjeta™ (human insulin [rDNA origin]) injection 100IU/mL for the treatment of type 1 and type 2 diabetes mellitus to improve glycemic control.
To orient ourselves, we mainly need two pieces of information: where am I and in which direction am I heading? Experiments in the rat have shown that these types of information are directly accessible and independently coded in the brain.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Garland R Tschudin, MD 5409 Butler Hill Rd, Saint Louis, MO 63128-4901 Ph: (314) 971-6576 | Dr Garland R Tschudin, MD 12348 Old Tesson Rd Ste 160, Saint Louis, MO 63128 Ph: (314) 467-3800 |
News Archive
Mesenchymal stem cells (MSCs) have been transplanted to successfully treat a variety of diseases and conditions. The benefit of using MSCs is their ability to self-renew and differentiate into a variety of specialized cell types, such as osteoblasts (cells contributing to bone formation), chondrocytes (cartilage cells), adipocytes (fat cells), myocardiocytes (the muscle cells that make up the cardiac muscle), and neurons (nervous system cells).
Ligand Pharmaceuticals Incorporated today announced that its licensee, Onyx Pharmaceuticals, received accelerated approval from the U.S. Food and Drug Administration (FDA) for Kyprolis (carfilzomib) for Injection, a proteasome inhibitor indicated for the treatment of patients with multiple myeloma who have received at least two prior therapies, including bortezomib and an immunomodulatory agent, and have demonstrated disease progression on or within 60 days of completion of the last therapy.
Biodel Inc. announced today that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) requesting additional information regarding the company's new drug application (NDA) for Linjeta™ (human insulin [rDNA origin]) injection 100IU/mL for the treatment of type 1 and type 2 diabetes mellitus to improve glycemic control.
To orient ourselves, we mainly need two pieces of information: where am I and in which direction am I heading? Experiments in the rat have shown that these types of information are directly accessible and independently coded in the brain.
› Verified 2 days ago
Dr. Nichole Gallegos Zehnder, MD General Practice Medicare: Accepting Medicare Assignments Practice Location: 4901 Forest Park Ave, Div Im General Med, Ste 241, Saint Louis, MO 63108 Phone: 314-362-5060 Fax: 314-362-6959 | |
Dr. Richard Thomas Griffey, MD General Practice Medicare: Medicare Enrolled Practice Location: 400 S Kingshighway Blvd, Dept Emergency Med, Saint Louis, MO 63110 Phone: 314-362-9123 Fax: 314-747-3338 | |
Dr. Laura Nicole Becker, MD General Practice Medicare: Medicare Enrolled Practice Location: 1465 S Grand Blvd, Saint Louis, MO 63104 Phone: 314-268-4095 | |
Grace Elizabeth Montes, MD General Practice Medicare: Medicare Enrolled Practice Location: 1 Barnes Jewish Hospital Plz, Saint Louis, MO 63110 Phone: 314-362-9177 | |
Mr. Rajendra Gavini, M.D. General Practice Medicare: Not Enrolled in Medicare Practice Location: 12101 Woodcrest Executive Dr, Suite 210, Saint Louis, MO 63141 Phone: 314-317-0600 Fax: 314-317-0606 | |
Iqra Ansari, MD General Practice Medicare: Not Enrolled in Medicare Practice Location: 2415 N Kingshighway Blvd, Saint Louis, MO 63113 Phone: 314-367-1083 |